Ethanol Ablation Therapy Drives Immune-Mediated Antitumor Effects in Murine Breast Cancer Models.

Nief, Corrine A; Swartz, Adam M; Chelales, Erika; Sheu, Lauren Y; Crouch, Brian T; Ramanujam, Nirmala; Nair, Smita K

Nief, Corrine A; Swartz, Adam M; Chelales, Erika; Sheu, Lauren Y; Crouch, Brian T; Ramanujam, Nirmala; Nair, Smita K.

Afiliação

Nief CA; Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA.
Swartz AM; Stanford School of Medicine, Stanford University, Stanford, CA 94305, USA.
Chelales E; Department of Surgery, Duke University School of Medicine, Durham, NC 27708, USA.
Sheu LY; Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA.
Crouch BT; Department of Surgery, Duke University School of Medicine, Durham, NC 27708, USA.
Ramanujam N; Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA.
Nair SK; Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA.

Cancers (Basel) ; 14(19)2022 Sep 25.

Article em En | MEDLINE | ID: mdl-36230591

Palavras-chave

breast cancer; immunomodulation; low-resource settings; myeloid derived supressor cells; tumor ablation; tumor microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google